Background It is not known whether prehospital fibrinolysis, coupled with timely coronary
angiography, provides a clinical outcome similar to that with primary percutaneous coronary …

Background Although P2Y 12 antagonists are effective in patients with non–ST-segment
elevation (NSTE) acute coronary syndromes, the effect of the timing of administration — before …

Context The contemporary decline in mortality reported in patients with ST-segment elevation
myocardial infarction (STEMI) has been attributed mainly to improved use of reperfusion …

Background Bivalirudin, as compared with heparin and glycoprotein IIb/IIIa inhibitors, has
been shown to reduce rates of bleeding and death in patients undergoing primary …

Background: ST-segment–elevation myocardial infarction (STEMI) and non–ST-segment–elevation
myocardial infarction (NSTEMI) management has evolved considerably over the …

Background— Intravenous thrombolysis remains a widely used treatment for ST-elevation
myocardial infarction; however, it carries a higher risk of reinfarction than primary PCI (PPCI). …

Background Primary percutaneous coronary intervention (PCI) for ST-elevation myocardial
infarction has traditionally been supported by unfractionated heparin, which has never been …

Background Clinical trials have not shown a benefit of high doses of epinephrine in the
management of cardiac arrest. We conducted a prospective, multicenter, randomized study …

Background— Limited data are available on the impact of prehospital thrombolysis (PHT) in
the “real-world” setting. Methods and Results— Of 443 intensive care units in France, 369 (…

Objective To determine the efficacy and safety of enoxaparin compared with unfractionated
heparin during percutaneous coronary intervention. Design Systematic review and meta-…